Home › NDC Lookup › RxCUI directory › RxCUI 1545150

Canagliflozin 150 MG / metformin hydrochloride 1000 MG Oral Tablet — RxCUI 1545150

Name: Canagliflozin 150 MG / metformin hydrochloride 1000 MG Oral Tablet (RxCUI 1545150)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1545150 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1545150

Official nameCanagliflozin 150 MG / metformin hydrochloride 1000 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known ascanagliflozin 150 MG / metFORMIN HCl 1000 MG Oral Tablet

FDA products mapped8

Package NDCs mapped8

Reported Medicaid activity (SDUD)2,694 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Canagliflozin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Invokana helps lower your blood sugar by making your kidneys pass extra glucose out in your urine rather than keeping it in your blood. On top of that, if you also have heart disea...
What exactly is Invokana supposed to do for me if I have type 2 diabetes?
This is a real risk worth knowing about. In large clinical trials, people taking Invokana had about twice the rate of lower limb amputations compared to those on placebo — most com...
I heard Invokana can cause amputations. How worried should I be?

📖 Read our full Canagliflozin guide →

🕸️ Concept Web — How Canagliflozin 150 MG / metformin hydrochloride 1... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Canagliflozin 150 MG / metformin hydrochloride 1000 MG Oral Tablet RxCUI 1545150 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 4

The active substance itself — no strength, form, or brand attached yet.
- Canagliflozin 1373458 IN
- Metformin 6809 IN
- Canagliflozin / metformin 1545149 MIN
- Metformin hydrochloride 235743 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Invokamet 1545151 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Canagliflozin / metformin Oral Tablet 1545148 SCDF
- Canagliflozin / metformin hydrochloride Oral Tablet 2647565 SCDFP
- Canagliflozin / metformin Oral Product 1545146 SCDG
- Canagliflozin / metformin Pill 1545147 SCDG
- Canagliflozin / metformin hydrochloride Oral Product 2663420 SCDGP
- Canagliflozin / metformin hydrochloride Pill 2659101 SCDGP
- Canagliflozin / metformin Oral Tablet [Invokamet] 1545153 SBDF
- Canagliflozin / metformin hydrochloride Oral Tablet [Invokamet] 2654503 SBDFP
- +5 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Canagliflozin 150 MG 1545145 SCDC
- Metformin hydrochloride 1000 MG 860995 SCDC
- Canagliflozin 150 MG / metformin hydrochloride 1000 MG Oral Tablet [Invokamet] 1545156 SBD
- Canagliflozin 150 MG / metformin hydrochloride 1000 MG [Invokamet] 1545152 SBDC

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Canagliflozin 150 MG SCDC · 1545145
Metformin hydrochloride 1000 MG SCDC · 860995
Canagliflozin / metformin Oral Tablet SCDF · 1545148
Canagliflozin / metformin hydrochloride Oral Tablet SCDFP · 2647565
Canagliflozin / metformin Oral Product SCDG · 1545146
Canagliflozin / metformin Pill SCDG · 1545147
Canagliflozin / metformin hydrochloride Oral Product SCDGP · 2663420
Canagliflozin / metformin hydrochloride Pill SCDGP · 2659101

Brand-Name Concepts

Canagliflozin 150 MG / metformin hydrochloride 1000 MG Oral Tablet [Invokamet] SBD · 1545156
Canagliflozin 150 MG / metformin hydrochloride 1000 MG [Invokamet] SBDC · 1545152
Canagliflozin / metformin Oral Tablet [Invokamet] SBDF · 1545153
Canagliflozin / metformin hydrochloride Oral Tablet [Invokamet] SBDFP · 2654503
Invokamet Oral Product SBDG · 1545154
Invokamet Pill SBDG · 1545155
Invokamet BN · 1545151

📦 FDA Products & Package NDCs

8 products · 8 package NDCs

8 package NDCs map to RxCUI 1545150 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
50458-0540-60	60 TABLET, FILM COATED in 1 BOTTLE (50458-540-60)	INVOKAMET	Janssen Pharmaceuticals, Inc.	2014-08-08
50458-0541-60	60 TABLET, FILM COATED in 1 BOTTLE (50458-541-60)	INVOKAMET	Janssen Pharmaceuticals, Inc.	2014-08-08
50458-0542-60	60 TABLET, FILM COATED in 1 BOTTLE (50458-542-60)	INVOKAMET	Janssen Pharmaceuticals, Inc.	2014-08-08
50458-0543-60	60 TABLET, FILM COATED in 1 BOTTLE (50458-543-60)	INVOKAMET	Janssen Pharmaceuticals, Inc.	2014-08-08
50458-0940-01	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-...	INVOKAMET XR	Janssen Pharmaceuticals, Inc.	2016-09-20
50458-0941-01	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-...	INVOKAMET XR	Janssen Pharmaceuticals, Inc.	2016-09-20
50458-0942-01	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-...	INVOKAMET XR	Janssen Pharmaceuticals, Inc.	2016-09-20
50458-0943-01	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-...	INVOKAMET XR	Janssen Pharmaceuticals, Inc.	2016-09-20

Observed labelers: Janssen Pharmaceuticals, Inc. (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.